Projects funded by the NCN
Effect of paroxetine and risperidone on the heterodimerization of dopamine D2 and serotonin 5-HT1A receptor in the context of obsessive-compulsive disorder
2012/05/N/NZ7/00664
Keywords:
paroxetine risperidone obsessive-compulsive disorder heterodimerization
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii PAN
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 3 - announced on 2012-03-15
Amount awarded: 99 710 PLN
Project start date (Y-m-d): 2013-02-05
Project end date (Y-m-d): 2016-02-04
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled